Discordance in early breast cancer for tumour grade, Estrogen Receptor, Progesteron Receptors and Human Epidermal Receptor-2 status between core needle biopsy and surgical excisional primary tumour

Breast

Volumn 20, Issue 3, 2011, Pages 284-287

  Lorgis, Veronique ^a   Algros, Marie Paule ^a   Villanueva, Cristian ^a   Chaigneau, Loic ^a   Thierry vuillemin, Antoine ^a   Nguyen, Thierry ^a   Demarchi, Martin ^a   Bazan, Fernando ^a   Sautiere, Jean Loup ^a   Maisonnette Lescot, Yolande ^a   Ringenbach, Frederic ^a   Bontemps, Patrick ^a   Pivot, Xavier ^a,b  

^a UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

^b INSERM   (France)

Author keywords

Breast cancer; Estrogen receptor; Human epidermal receptor 2; Progesteron receptor; Tumoral prognostic and predictive factors

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER GRADING; CANCER SURGERY; CLINICAL ASSESSMENT; CONTROLLED STUDY; EARLY CANCER; FEMALE; GENE OVEREXPRESSION; HUMAN; MAJOR CLINICAL STUDY; NEEDLE BIOPSY; PRIMARY TUMOR; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DETERMINATION; TUMOR VOLUME;

EID: 79957771921     PISSN: 09609776     EISSN: 15323080     Source Type: Journal    
DOI: 10.1016/j.breast.2010.12.007     Document Type: Article

References (15)

1. Benson S.R., Harrison N.J., Lengyel J., Deacon C., Isgar B. Combined image guidance excision of non-palpable breast lesions. Breast 2004, 13:110-114.
2. Verkooijen H.M., Peeters P.H., Pijnappel R.M., Koot V.C., Schipper M.E., Borel Rinkes I.H. Diagnostic accuracy of needle-localized open breast biopsy for impalpable breast disease. Br J Surg 2000, 87:344-347.
3. Connor C.S., Tawfik O.W., Joyce A.J., Davis M.K., Mayo M.S., Jewell W.R. A comparison of prognostic tumor markers obtained on image-guided breast biopsies and final surgical specimens. Am J Surg 2002, 184:322-324.
4. Sutela A., Vanninen R., Sudah M., Berg M., Kiviniemi V., Rummukainen J., et al. Surgical specimen can be replaced by core samples in assessment of ER, PR and HER-2 for invasive breast cancer. Acta Oncol 2008, 47:38-46.
5. Taucher S., Rudas M., Mader R.M., Gnant M., Dubsky P., Roka S., et al. Prognostic markers in breast cancer: the reliability of HER2/neu status in core needle biopsy of 325 patients with primary breast cancer. Wien Klin Wochenschr 2004, 116:26-31.
6. Gotzinger P., Gebhard B., Gnant M., Rudas M., Reiner A., Jakesz R. Chirurg 1998, 69:1068-1071.
7. Hodi Z., Chakrabarti J., Lee A.H., Ronan J.E., Elston C.W., Cheung K.L., et al. The reliability of assessment of oestrogen receptor expression on needle core biopsy specimens of invasive carcinomas of the breast. J Clin Pathol 2007, 60:299-302.
8. Harris K., Morafa I., Thomas V., Mokbel K. Core biopsy is accurate in determining the hormone receptor status of early breast cancer. Am J Surg 2004, 187:568. author reply 568.
9. Cavaliere A., Sidoni A., Scheibel M., Bellezza G., Brachelente G., Vitali R., et al. Biopathologic profile of breast cancer core biopsy: is it always a valid method?. Cancer Lett 2005, 218:117-121.
10. Burge C.N., Chang H.R., Apple S.K. Do the histologic features and results of breast cancer biomarker studies differ between core biopsy and surgical excision specimens?. Breast 2006, 15:167-172.
11. Badoual C., Maruani A., Ghorra C., Lebas P., Avigdor S., Michenet P. Pathological prognostic factors of invasive breast carcinoma in ultrasound-guided large core biopsies-correlation with subsequent surgical excisions. Breast 2005, 14:22-27.
12. Arnedos M., Nerurkar A., Osin P., A'Hern R., Smith I.E., Dowsett M. Discordance between core needle biopsy (CNB) and excisional biopsy (EB) for estrogen receptor (ER), progesterone receptor (PgR) and HER2 status in early breast cancer (EBC). Ann Oncol 2009, 20:1948-1952.
13. Park S.Y., Kim K.S., Lee T.G., Park S.S., Kim S.M., Han W., et al. The accuracy of preoperative core biopsy in determining histologic grade, hormone receptors, and human epidermal growth factor receptor 2 status in invasive breast cancer. Am J Surg 2009, 197:266-269.
14. Zidan A., Christie Brown J.S., Peston D., Shousha S. Oestrogen and progesterone receptor assessment in core biopsy specimens of breast carcinoma. J Clin Pathol 1997, 50:27-29.
15. Wolff A.C., Hammond M.E., Schwartz J.N., Hagerty K.L., Allred D.C., Cote R.J., et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. Arch Pathol Lab Med 2007, 131:18-43.